%0 Journal Article
%T Comparative Efficacy of Flow Diverter Devices in the Treatment of Carotid Sidewall Intracranial Aneurysms: a Retrospective, Multicenter Study.
%A Dmytriw AA
%A Salim HA
%A Musmar B
%A Cancelliere NM
%A Griessenauer CJ
%A Regenhardt RW
%A Jones J
%A Tutino V
%A Hasan Z
%A Limbucci N
%A Lay SV
%A Spears J
%A Rabinov JD
%A Harrigan MR
%A Siddiqui AH
%A Levy EI
%A Stapleton CJ
%A Renieri L
%A Cognard C
%A Shaikh H
%A Kühn AL
%A Möhlenbruch MA
%A Tjoumakaris SI
%A Jabbour P
%A Taussky P
%A Settecase F
%A Heran MKS
%A Nguyen A
%A Volders D
%A Harker P
%A Devia DA
%A Puri AS
%A Psychogios M
%A Puentes JC
%A Leone G
%A Buono G
%A Tarantino M
%A Muto M
%A Briganti F
%A Dalal S
%A Gontu V
%A Alcedo Guardia RE
%A Vicenty-Padilla JC
%A Brouwer P
%A Schmidt MH
%A Schirmer C
%A Pickett GE
%A Andersson T
%A Söderman M
%A Marotta TR
%A Cuellar-Saenz H
%A Thomas AJ
%A Patel AB
%A Mendes Pereira V
%A Adeeb N
%A  
%J Clin Neuroradiol
%V 0
%N 0
%D 2024 Jul 18
%M 39023541
%F 3.156
%R 10.1007/s00062-024-01435-x
%X <B>BACKGROUND: </B>The comparative efficacy and safety of first-generation flow diverters (FDs), Pipeline Embolization Device (PED) (Medtronic, Irvine, California), Silk (Balt Extrusion, Montmorency, France), Flow Re-direction Endoluminal Device (FRED) (Microvention, Tustin, California), and Surpass Streamline (Stryker Neurovascular, Fremont, California), is not directly established and largely inferred.<BR><B>OBJECTIVE: </B>This study aimed to compare the efficacy of different FDs in treating sidewall ICA intracranial aneurysms.<BR><B>METHODS: </B>We conducted a retrospective review of prospectively maintained databases from eighteen academic institutions from 2009-2016, comprising 444 patients treated with one of four devices for sidewall ICA aneurysms. Data on demographics, aneurysm characteristics, treatment outcomes, and complications were analyzed. Angiographic and clinical outcomes were assessed using various imaging modalities and modified Rankin Scale (mRS). Propensity score weighting was employed to balance confounding variables. The data analysis used Kaplan-Meier curves, logistic regression, and Cox proportional-hazards regression.<BR><B>RESULTS: </B>While there were no significant differences in retreatment rates, functional outcomes (mRS 0-1), and thromboembolic complications between the four devices, the probability of achieving adequate occlusion at the last follow-up was highest in Surpass device (HR: 4.59; CI: 2.75-7.66, p < 0.001), followed by FRED (HR: 2.23; CI: 1.44-3.46, p < 0.001), PED (HR: 1.72; CI: 1.10-2.70, p = 0.018), and Silk (HR: 1.0 ref. standard). The only hemorrhagic complications were with Surpass (1%).<BR><B>CONCLUSIONS: </B>All the first-generation devices achieved good clinical outcomes and retreatment rates in treating ICA sidewall aneurysms. Prospective studies are needed to explore the nuanced differences between these devices in the long term.